Immunobiological cold chain performance assessment in Brazil: mixed methods research Authors: Gabriela Gonçalves Amaral, Ione Carvalho Pinto, Thayane Ingrid Xavier de Andrade, Brener Santos Silva, Eliete Albano de Azevedo Guimarães, Valéria Conceição de Oliveira Published: 2026 ABSTRACT AbstractBackgroundCold chain maintenance is essential to prevent changes in the composition, efficacy, and potency of immunobiologicals, thereby ensuring their immunogenicity.ObjectiveTo evaluate the performance of the immunobiological cold chain in vaccination rooms located in Primary Health Care units in Brazil.MethodsThis mixed-methods study employed a sequential explanatory design (QUAN→qual) and was conducted in vaccination rooms across different regions of Brazil between 2021 and 2022. States, municipalities, and vaccination rooms were selected using multistage probabilistic sampling. In the quantitative phase, an analytical cross-sectional study was conducted using the Immunobiological Agent Conservation Assessment Scale, applied to nursing professionals, along with the collection of municipal-level indicators. Logistic regression was used to identify factors associated with adequate cold chain performance. In the qualitative phase, a descriptive-exploratory study was conducted with state, regional, and municipal managers, as well as nursing professionals. Data were collected through individual semi-structured interviews and analyzed using thematic content analysis. Integration of quantitative and qualitative data was performed through a connecting approach, including the development of joint displays and meta-inferences.ResultsCold chain performance at the national level was classified as inadequate. DTPw-HB/Hib vaccination coverage (OR: 1.029; 95% CI: 1.007–1.052) and urban location (OR: 1.034; 95% CI: 1.013–1.055) were identified as factors associated with adequate performance. Qualitative findings revealed structural, logistical, and organizational challenges, including regional inequalities, transportation difficulties, infrastructure limitations, and financial constraints, which influence cold chain performance.ConclusionsThe performance of the immunobiological cold chain in Brazil was classified as inadequate and was associated with geographic factors, such as the country’s large territorial extension and climatic diversity, which primarily affect the transportation of immunobiologicals, as well as limitations in physical infrastructure, regional financial inequalities, and weaknesses in municipal-level management.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12913-026-15000-4.Keywords: Evaluation study, Immunization programs, Vaccines, Refrigeration, Cold chain, Brazil Introduction Immunization is one of the most cost-effective interventions for public health and global development, responsible for saving millions of lives annually. The availability of immunobiologicals capable of preventing more than 20 diseases averts approximately 3.5 to 5 million deaths each year [1, 2]. The success of National Immunization Programs in reducing, eliminating, and eradicating these diseases is attributed, among other factors, to the continuous incorporation of new immunobiologicals, the expansion of vaccination schedules, and the maintenance of high and homogeneous vaccination coverage [2–5], as well as to the adoption of appropriate practices for maintaining the immunobiological cold chain [6, 7]. The cold chain encompasses the entire logistical pathway of immunobiologicals, from manufacturing to administration to users, requiring adequate conditions for storage, transportation, and handling to ensure their chemical, physical, and biological stability [7–9]. These measures are essential to prevent changes in composition, efficacy, and potency, thereby ensuring immunogenicity [10, 11]. In Brazil, the cold chain is organized hierarchically at the national, state, and municipal levels, with the latter being responsible for the operation of vaccination rooms [8]. According to recommendations from the World Health Organization and the Centers for Disease Control and Prevention, at the municipal level and in vaccination rooms, immunobiologicals must be stored and transported at positive temperatures between + 2 °C and + 8 °C. At the national and state levels, some immunobiologicals may be maintained at negative temperatures between − 25 °C and − 15 °C, according to manufacturers’ guidelines [8, 12]. Exposure of immunobiologicals to inappropriate temperatures, whether due to heat or freezing, compromises their quality, reduces shelf life, and may lead to irreversible loss of potency [8, 12–14]. Failures in maintaining the cold chain may result in lack of immunological protection or the occurrence of adverse events, in addition to generating waste and increasing costs for National Immunization Programs [15–17]. Strengthening the cold chain at the municipal level and within vaccination rooms is therefore recognized as a strategic component for the success of the Brazilian National Immunization Program. However, such strengthening depends directly on the adequacy of infrastructure, the performance of operational processes, and the knowledge, training, and commitment of healthcare teams responsible for managing vaccination rooms [18–20]. In this context, systematic evaluations of the cold chain are necessary to determine whether its structure and organization are sufficient to support the continuous incorporation of immunobiologicals and to ensure their proper maintenance in vaccination rooms [5, 21]. Despite its relevance for the sustainability and performance of National Immunization Programs, studies that comprehensively assess cold chain performance in Primary Health Care vaccination rooms across different regions of Brazil remain scarce, particularly in a country of continental dimensions marked by significant regional and socioeconomic inequalities. Given this scenario, we hypothesize that the performance of the cold chain in vaccination rooms across Brazilian municipalities presents weaknesses, with variations influenced by geographic, structural, procedural, and organizational factors. This study aimed to evaluate the performance of the immunobiological cold chain in vaccination rooms located in Primary Health Care units in Brazil. Methods Study design This is a mixed-methods study with a sequential explanatory design (QUAN→qual), characterized by the collection and analysis of quantitative data followed by the collection and analysis of qualitative data [22]. In the quantitative phase, an analytical cross-sectional study was conducted to measure the performance of the cold chain in vaccination rooms. In the qualitative phase, a descriptive-exploratory study was carried out across different levels of the cold chain in Brazilian regions, aiming to identify associated factors and to understand how these factors influence the performance of the cold chain. To ensure methodological rigor, the recommendations of the Strengthening the Reporting of Observational Studies in Epidemiology were followed for the quantitative phase, the Consolidated Criteria for Reporting Qualitative Research for the qualitative phase, and the Mixed Methods Appraisal Tool for the mixed-methods approach. Study location and period The study was conducted in vaccination rooms of Primary Health Care Units located in municipalities across the five Brazilian regions (North, Northeast, Midwest, Southeast, and South), between 2021 and 2022. Population and sample Quantitative phase In the quantitative phase, to capture the diversity of the cold chain in Brazil, states, municipalities, and vaccination rooms were selected using a multistage probabilistic sampling strategy. The design aimed to include different organizational and regional contexts. However, no sampling weights or design-based analyses were applied; therefore, the results should be interpreted as descriptive of the studied sample, and statistical inference at the national level is not warranted. The sampling procedure to estimate the number of states, municipalities, and vaccination rooms was conducted in three stages (Supplementary Material 1) (Fig. 1). Data on total population and vaccination coverage for the pentavalent vaccine (diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b - DTPw-HB/Hib) for the year 2019 were used [23, 24]. CONSORT flow diagram of the sampling procedure, Brazil, 2022 In the first stage (selection of states), cluster sampling was adopted, considering each state as a cluster. Clusters were selected using probability proportional to size, based on the total state population in 2019 [24]. This strategy ensured the inclusion of at least one state per region, resulting in eight states. Subsequently, states were randomly selected within each region (North: Amazonas; Northeast: Ceará, Pernambuco, and Bahia; Midwest: Goiás; Southeast: Rio de Janeiro and São Paulo; South: Santa Catarina). In the second stage (selection of municipalities), simple random sampling was used to select municipalities within each previously selected state [25], considering a significance level of 5% (α = 0.05) and a margin of error of 10% (d = 0.10). Within each state, 10 municipalities were selected and stratified by population size: seven municipalities with up to 20,000 inhabitants, two with populations between 20,001 and 100,000 inhabitants, and one with more than 100,000 inhabitants [26], totaling 80 municipalities. Municipalities were then randomly selected within each state and population stratum and contacted for participation. In cases of refusal, a new draw was conducted within the same state and stratum. In the third stage (selection of vaccination rooms), after municipal participation was confirmed, 475 vaccination rooms across the 80 municipalities were identified. The sample size calculation considered a 95% confidence interval, a variance of 0.5, and a margin of error of 5%, resulting in a sample of 212 vaccination rooms (45% of the total). Additional criteria were adopted to maintain sample balance: municipalities with up to two vaccination rooms had all rooms included; those with three to five rooms had 50% selected; and those with six or more rooms had 40% selected. Thus, the initially planned sample consisted of 227 vaccination rooms, randomly selected through a draw, which was repeated in cases of refusal. However, due to higher-than-expected participation during data collection, all eligible rooms that agreed to participate were included, resulting in a final sample of 280 vaccination rooms analyzed (Fig. 1). Although a multistage sampling strategy was employed to ensure representation of different Brazilian regions and municipal population sizes, analyses were conducted at the level of vaccination rooms without weighting. For inferential analyses, the municipality was considered the unit of analysis. The selection of states and municipalities was conducted independently by a statistician with no involvement in the project and without interference from the research team. The selection of vaccination rooms was carried out by the principal investigator using a sampling software, based on an available list of rooms. Urban and rural vaccination rooms within the public health system linked to Primary Health Care units and with adequate physical infrastructure for vaccination activities were included. Exclusion criteria comprised rooms used only as support points in rural areas, those located in hospitals and/or emergency care units, inactive rooms, and those exclusively dedicated to COVID-19 vaccination campaigns. Regarding the interviewed professionals, one participant per vaccination room was included, with at least six months of experience in vaccination activities, considered the minimum period required to perform actions related to the conservation of immunobiologicals. Qualitative phase The qualitative phase was expanded from the original study protocol to include stakeholders involved in cold chain management at the state, regional, and municipal levels, as well as nursing professionals working in vaccination rooms. Due to the COVID-19 pandemic, interviews were conducted remotely. These modifications were reviewed and approved by the Research Ethics Committee of the proposing institution (opinion 8,428,540). In this phase, state immunization technical staff (SITS), regional immunization technical staff (RITS), municipal immunization technical staff (MITS), and nursing professionals working in vaccination rooms were included. Participants were selected purposively, guided by the mean scores obtained by municipalities in the quantitative phase, in order to capture different levels of cold chain performance and to deepen the understanding of factors associated with the results identified in that phase. Professionals with at least six months of experience in vaccination activities were included. The sample comprised 42 participants: seven state-level representatives, 11 regional-level, 11 municipal-level, and 13 professionals working in vaccination rooms. Data collection To characterize the municipalities, sociodemographic data and indicators were collected from governmental websites at the national, state, and municipal levels. Sociodemographic variables included population size, the Social Vulnerability Index for 2010, and the Municipal Human Development Index for 2010. Coverage-related variables included Primary Health Care coverage in 2019, Family Health Strategy coverage in 2019, DTPw-HB/Hib vaccine coverage, and vaccination coverage homogeneity—an indicator established within the Previne Brasil Program and used for financial transfers aimed at expanding access to and continuity of care in Primary Health Care Units [27]. The socioeconomic indicators (Social Vulnerability Index and Municipal Human Development Index) refer to 2010, corresponding to the most recent nationally available dataset. These indicators were used as they represent relatively stable structural determinants over time. Vaccination coverage indicators were based on 2019 data, representing the most recent period prior to the COVID-19 pandemic, thereby avoiding potential distortions related to changes in health service delivery during the pandemic. This approach aimed to ensure greater consistency in the interpretation of the analyzed associations. Data collection to assess cold chain performance in vaccination rooms was initially conducted through contact with the coordination of the Brazilian National Immunization Program, which mediated communication with states, which in turn informed the selected municipalities. Subsequently, municipal immunization staff were contacted via email and/or telephone to obtain contact information for the professionals responsible for the vaccination rooms. These professionals were then invited to participate in the study. After agreement to participate, a link to access the informed consent form was sent via email or messaging application, formalizing participation. Data were collected individually through telephone interviews conducted by the researcher, either by reading a presentation letter or by sending a link to access the data collection instrument via a messaging application. Participants were informed about the voluntary nature of participation and that the results would be used exclusively for scientific publication purposes. Each participant was assigned a code to ensure anonymity. The Immunobiological Agent Conservation Assessment Scale (EACI - Escala de Avaliação da Conservação de Imunobiológicos), developed and validated for the Brazilian context, was used as the data collection instrument to measure cold chain performance in vaccination rooms [28]. The EACI consists of five evaluative items using a Likert-type scale with ordinal response options and symmetrical extremes: never (0), almost never (1), almost always (2), and always (3), as well as seven descriptive items intended to support the evaluation of vaccination rooms. The total EACI score ranges from 0 to 15 points and is categorized as 0–9 points (inadequate cold chain performance) and 10–15 points (adequate performance), based on the cut-off established in the validation study [28]. It should be noted that only the evaluative items of the EACI were used in this study. The instrument is owned by the researcher, and no authorization was required for its use. Although previously validated, a pilot study was conducted in a municipality not included in the study setting to assess its comprehensibility. Understanding was confirmed, and no adaptations were necessary. For the qualitative approach, individual online interviews were conducted using a semi-structured guide based on key questions related to the management and performance of the cold chain. A specific interview guide was developed for each level of the cold chain, considering their distinct roles and responsibilities (Supplementary Material 2). A pilot study was conducted in a municipality not included in the study setting. Theoretical saturation was not used as a criterion to define the number of participants, as participant selection was guided by the results of the quantitative phase. Instead, efforts were made to include participants from municipalities with different EACI score classifications, ensuring representation of diverse cold chain performance contexts. Interviews were audio-recorded in digital format and subsequently transcribed verbatim to ensure data reliability. Participant anonymity was ensured by identifying individuals according to their professional role (SITS, RITS, MITS, nurse = NUR / nursing technician = TEC), combined with the EACI score and corresponding region (e.g., SITS9 – North; RITS11 – South; MITS10 – Midwest; NUR5 – Northeast; TEC10 – South). Data analysis In the descriptive analysis, variables were presented as absolute and relative frequencies. Mean scores obtained by vaccination rooms using the EACI were used as an indicator to classify cold chain performance at the municipal, state, and national levels. Cold chain performance was initially measured at the level of vaccination rooms using the EACI. Subsequently, for analyses at the municipal level, the scores obtained by vaccination rooms were aggregated by municipality using the mean score of the rooms evaluated in each location. This approach allowed for the synthesis of vaccination room performance at the municipal level, taking into account variability across units. To assess associations, a logistic regression model was applied to identify variables associated with increased or decreased likelihood of adequate cold chain performance (dependent variable) at the municipal level. Independent variables were selected based on evidence from the literature regarding structural, organizational, and primary health care coverage factors that may influence cold chain performance, as well as their theoretical plausibility. Given that independent variables were available at the municipal level, inferential analyses were conducted using the municipality as the unit of analysis. Initially, univariate analyses were performed, considering each independent variable separately in relation to the dependent variable. Variables with a p-value ≤ 0.20 were selected for inclusion in the multivariable analysis, a strategy commonly adopted in exploratory epidemiological studies to identify candidate variables for the final model. The final multivariable model included only variables with p ≤ 0.05. Final variable selection also considered the consistency of estimated effects and the epidemiological plausibility of the results. Model goodness-of-fit was assessed using the Hosmer–Lemeshow test, with p > 0.05 indicating an adequate fit. Results were presented as odds ratios (OR) with corresponding 95% confidence intervals. Quantitative data were processed and analyzed using the Statistical Package for the Social Sciences, version 25.0, and the R software, version 4.2.2. For the qualitative approach, data analysis was based on thematic content analysis, focusing on the meanings embedded in participants’ narratives, following the stages of pre-analysis, material exploration, data treatment, inference, and interpretation [29]. To identify convergences and divergences, qualitative and quantitative data were integrated after separate analyses through a connecting approach, including the development of joint displays and the generation of meta-inferences [30]. Meta-inferences refer to conclusions derived from the integration of findings, providing a more comprehensive understanding of the phenomenon under investigation in mixed-methods research [22, 31]. Figure 2 presents a synthesis of the methodological pathway adopted in this study. Schematic representation of the methodological pathway of a mixed-methods study with a sequential explanatory design (QUAN→qual), Brazil, 2022 Results A total of 280 vaccination rooms across 80 municipalities (small-sized: n = 56, 70%; medium-sized: n = 16, 20%; large-sized: n = 8, 10%) from the five Brazilian regions were assessed. A proportion of these rooms were located in Primary Health Care units operating under the Family Health Strategy model (n = 127, 45.3%), which is recommended for the organization of Primary Health Care in Brazil, and most were situated in urban areas (n = 219, 78.3%) (data not shown). Only 77 (27.5%) vaccination rooms reported always having batteries or generators available in the event of power outages, and 74 (26.4%) had additional temperature monitoring devices beyond standard, maximum, and minimum thermometers. These resources were less frequently observed in the Northeast region (Table 1). Additionally, eight (2.9%) rooms still used analog mercury/alcohol thermometers (data not shown). Table 1Performance of the immunobiological cold chain in vaccination rooms according to Brazilian regions (N = 280), Brazil, 2022ItemsRegionsn (%)NeverAlmost neverAlmost alwaysAlwaysAvailability of batteries or generators in case of power grid failuresNorth15 (5.4)4 (1.4)2 (0.7)8 (2.9)Northeast104 (37.1)3 (1.1)7 (2.5)33 (11.8)Midwest15 (5.4)-1 (0.4)14 (5.0)Southeast33 (11.8)3 (1.1)3 (1.1)17 (6.1)South9 (3.2)1 (0.4)3 (1.1)5 (1.8)Total176 (62.8)11 (4.0)16 (5.7)77 (27.5)Presence of other temperature measuring instruments in addition to current, maximum and minimum thermometersNorth10 (3.6)3 (1.1)4 (1.4)12 (4.3)Northeast107 (38.2)5 (1.8)9 (3.2)26 (9.3)Midwest16 (5.7)-2 (0.7)12 (4.3)Southeast34 (12.1)4 (1.4)1 (0.4)17 (6.1)South10 (3.6)-1 (0.4)7 (2.5)Total177 (63.2)12 (4.3)17 (6.1)74 (26.4)Immunization room equipped with a refrigerated chamber for storing immunobiological agentsNorth13 (4.6)--16 (5.7)Northeast77 (27.5)--70 (25.0)Midwest4 (1.4)--26 (9.3)Southeast17 (6.1)--39 (13.9)South1 (0.4)--17 (6.1)Total112 (40.0)--168 (60.0)Transport, from the municipal authority to immunization rooms, in an air-conditioned car or with air conditioning onNorth4 (1.4)2 (0.7)6 (2.1)17 (6.1)Northeast21 (7.5)9 (3.2)43 (15.4)74 (26.4)Midwest1 (0.4)-4 (1.4)25 (8.9)Southeast8 (2.9)3 (1.1)10 (3.6)35 (12.5)South1 (0.4)1 (0.4)5 (1.8)11 (3.9)Total35 (12.6)15 (5.4)68 (24.3)162 (57.8)Air-conditioned immunization room (between + 18 °C and + 20 °C)North2 (0.7)2 (0.7)3 (1.1)22 (7.9)Northeast28 (10.0)3 (1.1)24 (8.6)92 (32.9)Midwest1 (0.4)1 (0.4)4 (1.4)24 (8.6)Southeast6 (2.1)4 (1.4)8 (2.9)38 (13.6)South--5 (1.8)13 (4.6)Total37 (13.2)10 (3.6)44 (15.7)189 (67.5) Performance of the immunobiological cold chain in vaccination rooms according to Brazilian regions (N = 280), Brazil, 2022 More than half of the rooms were equipped with refrigerated chambers for immunobiological storage (n = 168, 60.0%) and maintained air-conditioned environments with temperatures between + 18 °C and + 20 °C (n = 189, 67.5%). The Northeast region stood out for having a higher proportion of rooms without refrigerated chambers (n = 77, 27.5%) and without air conditioning (n = 28, 10.0%) (Table 1). Most rooms with refrigerated chambers and air conditioning had acquired this equipment before 2020 (n = 100, 35.7% and n = 213, 76.1%, respectively). In some cases, transportation of immunobiologicals from municipal authorities to vaccination rooms was consistently carried out using air-conditioned vehicles (n = 162, 57.8%) (Table 1). Among the 280 vaccination rooms analyzed, 180 (64.3%) showed inadequate cold chain performance. The highest proportion of inadequacy was observed in the Northeast region (n = 112; 40.0%) (Table 2). Table 2Immunobiological cold chain performance by vaccionations rooms (N = 280), Brazil, 2022LocationAssessed immunization roomsn (%)Vaccination room scorean (%)AdequateInadequate North region 29 (10.4) 15 (5.4) 14 (5.0) Amazon29 (10,4)15 (5.4)14 (5.0) Northeast region 147 (52.5) 35 (12.5) 112 (40.0) Bahia44 (15.7)9 (3.2)35 (12.5) Ceará54 (19.3)9 (3.2)45 (16.1) Pernambuco49 (17.5)17 (6.1)32 (11.4) Midwest region 30 (10.7) 21 (7.5) 9 (3.2) Goiás30 (10.7)21 (7.5)9 (3.2) Southeast region 56 (20.0) 20 (7.1) 36 (12.9) Rio de Janeiro30 (10.7)8 (2.9)22 (7.9) São Paulo26 (9.3)12 (4.3)14 (5.0) South region 18 (6.4) 9 (3.2) 9 (3.2) Santa Catarina18 (6.4)9 (3.2)9 (3.2) Brazil 280 (100) 100 (35.7) 180 (64.3) a Classification measured by the Immunobiological Agent Conservation Assessment Scale for Brazilian regions and states Immunobiological cold chain performance by vaccionations rooms (N = 280), Brazil, 2022 a Classification measured by the Immunobiological Agent Conservation Assessment Scale for Brazilian regions and states Among the 80 municipalities, 41 (51.3%) were classified as having inadequate cold chain performance. Six municipalities achieved the maximum EACI score, located in the states of Pernambuco (one municipality), Goiás (one municipality), São Paulo (two municipalities), and Santa Catarina (two municipalities). Figure 3 shows a concentration of municipalities with inadequate performance in the Northeast region, whereas municipalities in the South and Southeast regions exhibited a higher proportion of adequate performance. Classification of cold chain performance for immunobiologicals across Brazilian municipalities by region (N = 80), Brazil, 2022 Immunobiological cold chain performance in Brazil was classified as inadequate, with a mean EACI score of nine points. At the regional level, the North and Northeast were also classified as having inadequate performance. In the Southeast region, the state of Rio de Janeiro was identified as having inadequate performance (Table 3). Table 3Immunobiological cold chain performance by Brazilian regions and states (N = 80), Brazil, 2022LocationNumber of municipalitiesAssessed immunization roomsScore EACIaClassificationb North region 10 29 9 Inadequate Amazon10299Inadequate Northeast region 30 147 8 Inadequate Bahia10448Inadequate Ceará10546Inadequate Pernambuco10498Inadequate Midwest region 10 30 11 Adequate Goiás103011Adequate Southeast region 20 56 10 Adequate Rio de Janeiro10309Inadequate São Paulo102611Adequate South region 10 18 11 Adequate Santa Catarina101811Adequate Brazil 80 280 9 Inadequate a Mean score and b classification measured by the Immunobiological Agent Conservation Assessment Scale for Brazilian regions and states Immunobiological cold chain performance by Brazilian regions and states (N = 80), Brazil, 2022 a Mean score and b classification measured by the Immunobiological Agent Conservation Assessment Scale for Brazilian regions and states In the univariate analysis, four variables were identified as potentially associated with adequate cold chain performance in Brazilian municipalities: Municipal Human Development Index, Social Vulnerability Index, DTPw-HB/Hib vaccine coverage, and geographic location (Table 4). Table 4Univariate analysis of factors associated with immunobiological cold chain performance in Brazilian municipalities (N = 80), Brazil, 2022VariablesORa95%CIbp-valuePopulation size ≤ 20,000 inhabitants (small)10.905 20,001 to 100,000 inhabitants (average)0.7780.254–2.3790.660 > 100,000 inhabitants (large)1.0000.227–4.4001,000Municipal Human Development Indexc1.9801.144–3.428 0.015 Social Vulnerability Indexc0.7350.540–0.998 0.049 Primary Care coverage (%)0.9900.961–1.0200.499Family Health Strategy coverage (%)0.9910.969–1.0140.460Vaccination coverage - DTPw-HB/Hib (%)1.0201.000–1.039 0.046 Vaccination coverage homogeneity (%)1.0230.980–1.0700.262Location – urban area (%)1.0281.008–1.049 0.006 Vaccination carried out by a nurse (%)0.9990.988–1.0110.907Work schedule in the room - yes (%)0.9990.988–1.0110.921a OR: Odds Ratio; b CI: Confidence interval; cOdds ratios and their respective confidence intervals should be interpreted considering that the variable was scaled from 0 to 1; thus, the reported effects correspond to a 0.1-unit increase/decrease in the index Univariate analysis of factors associated with immunobiological cold chain performance in Brazilian municipalities (N = 80), Brazil, 2022 a OR: Odds Ratio; b CI: Confidence interval; cOdds ratios and their respective confidence intervals should be interpreted considering that the variable was scaled from 0 to 1; thus, the reported effects correspond to a 0.1-unit increase/decrease in the index Multivariable analysis identified DTPw-HB/Hib vaccine coverage and urban location as factors associated with adequate immunobiological cold chain performance in Brazilian municipalities (Table 5). Higher levels of vaccination coverage and a greater proportion of vaccination rooms located in urban areas were associated with an increased likelihood of adequate cold chain performance. Table 5Multivariable analysis of factors associated with immunobiological cold chain performance in Brazilian municipalities (N = 80), Brazil, 2022VariablesORa95%CIbp-valueVaccination coverage - DTPw-HB/Hib (%)1.0291.007–1.0520.011Location – urban area (%)1.0341.013–1.0550.002a OR: Odds Ratio; b CI: Confidence Interval. Classification table: 66.3% Multivariable analysis of factors associated with immunobiological cold chain performance in Brazilian municipalities (N = 80), Brazil, 2022 a OR: Odds Ratio; b CI: Confidence Interval. Classification table: 66.3% Based on the quantitative findings, 42 interviews were conducted with state (n = 7), regional (n = 11), and municipal (n = 11) managers, as well as professionals working in vaccination rooms (n = 13). Most participants were women (85.7%) and nurses (76.1%), held permanent positions (66.6%), were aged between 23 and 64 years (median = 41 years), and had between one and 44 years of experience in immunization activities. From the qualitative analysis, the thematic category “Brazilianness: regional interfaces in cold chain management” emerged, highlighting the diversity of Brazilian regions and their influence on cold chain performance. Reported challenges included geographic distances, diversity of transportation modes, climatic conditions, and poor road infrastructure. The need for climate-controlled vaccination rooms and the influence of urban location on the transportation and storage of immunobiologicals were also emphasized. In addition, financial, bureaucratic, and municipal management constraints were identified as factors hindering the adequate maintenance of the cold chain. Brazilianness: regional interfaces in cold chain management Brazil’s extensive geographic diversity poses logistical challenges for the cold chain, requiring the use of different modes of transportation across administrative levels. These challenges are more pronounced in the North and Northeast regions of the country: “What matters most is the issue of transport from the state to the municipalities, because there is a diversity of transport; it goes by river, by air and sometimes land route, and the distances that these municipalities have from the state capital, where our [state] headquarters is located. Sometimes, we make [immunobiological agents] available and the municipality doesn’t take it immediately. There are some that have difficulty accessing them, they only go by plane, and these municipalities have difficulty purchasing aircraft. So, sometimes, they need the state government plane to go there” [SITS9 - North]. Seasonal variations in river systems, including dry and flood periods, pose significant challenges for the transportation of immunobiologicals and the performance of the cold chain: “So, in addition to the distance, we have this water system, drought and flood… so, the biggest difficulty is maintaining the temperature that leaves the state to reach the municipality at a recommended temperature of + 2°C to + 8°C” [SITS9 - North]. Poor road conditions also represent a challenge that may compromise the transportation of immunobiologicals: “When they arrive at the regional offices, the municipalities pick up the vaccines through their individual transport. They are generally normal passenger cars” [SITS6 - Northeast]. “Cars break down very easily because they cannot handle the daily journey on dirt roads. Sometimes it breaks down on the way, you have to go back. So, I’ll reschedule the delivery for next week and we’ll move on” [MITS6 - Northeast]. Brazil is a country of continental dimensions, characterized by substantial climatic variation, with lower temperatures in the Midwest and South regions and higher temperatures in the North and Northeast. This climatic diversity requires climate-controlled vaccination rooms to ensure that immunobiologicals are maintained within recommended temperature ranges: “We have air conditioning in all rooms, it is a requirement that we have air conditioning… because here [the Southern region] we also have a lot of temperature fluctuation; it drops too much or rises too much, depending on the time of year” [SITS11 - South]. “We try not to vaccine in the afternoon so as not to open the refrigerator, because the immunization room is very hot” [NUR3 - Northeast]. “We only work with air conditioning. When there is a problem, we report it to the municipal management and we stop opening the domestic refrigerator and using the vaccines until the air conditioning problem is solved” [NUR7 - Northeast]. An association was observed between a higher likelihood of adequate cold chain performance in municipalities and a greater proportion of vaccination rooms located in urban areas. Vaccination rooms in urban settings generally have better accessibility, whereas rural areas tend to be more remote and less accessible. This may result in logistical challenges for the proper transportation and storage of vaccines: “For us here in urban areas, it is very peaceful. I see the vaccination team in rural areas struggling with transporting vaccines, especially during the rainy season, and it is very complicated” [NUR3 - Northeast]. “We have five immunization rooms in rural areas. The closest has 28 km of dirt road, which if it rains… the others are 60 km further. So, we make the delivery schedule for the month, if it rains or there is some other problem with the roads, my schedule will be lost” [MITS6 - Northeast]. Regions with greater financial resources are more likely to have the infrastructure and equipment necessary to ensure the proper storage and conservation of immunobiologicals: “We have maintenance, which I think is very important… it is very important to have a maintenance team, because if there is a failure of the generator, this team is ready to try to solve it, so this is very good” [SITS11 - Southeast]. “We are, as far as possible, always trying to support the municipalities and favor this issue of maintaining their municipal bodies… we also buy coolers, thermometers, we donate them to them” [SITS9 - Southeast]. These reports provide contextual evidence that the availability of financial and technical resources may contribute to better cold-chain maintenance conditions. However, regions with fewer financial resources may face additional challenges in acquiring the inputs and services required to maintain the cold chain: “Most of our regional bodies do not have generators… so this ends up being a very big difficulty” [SIT6 - Northeast]. “Our cold room is already quite old [built in 1997] … so, today it is insufficient, it is already old, we need to maintain a team that carries out constant maintenance” [SITS9 - North]. Financial constraints and limitations in municipal management contribute to greater difficulties in maintaining appropriate temperature conditions for immunobiologicals at municipal and local levels: “There is practically no loss of vaccine either at the state or regional level, the entire demand [loss of immunobiological agents] belongs to the municipality” [SITS8 - Northeast]. “Most of the time, we do not have a preventive and corrective maintenance contract within the municipalities” [SITS6 - Northeast]. “Over time, the cold chain has evolved a lot… but we need to guarantee a greater form of financing so that we can, in fact, make this chain work properly up to the municipality, because we can do state and regional. But when it arrives in the municipality… municipal management does not give it its due value” [SITS8 - Northeast]. “We have many municipal bodies that do not meet the Brazilian National Immunization Program standards, do not meet the technical notes, nor the municipal manual” [RITS4 - Northeast]. “It’s difficult the head [municipality]… the managers in the municipalities, they don’t understand the process. The only interest they have today, always in everything, is to have staff, a trained vaccinator” [SITS11 - South]. Although the Brazilian National Health Surveillance Agency (ANVISA) established in 2017 the replacement of domestic refrigerators with refrigerated chambers for vaccine storage, considerable variability in adherence to this recommendation was observed across vaccination rooms, in addition to deficiencies related to preventive maintenance. Participants reported that this regulatory requirement had been in place for several years: “… Since 2017, Resolution No. 197/2017 established that vaccines can no longer be stored in domestic refrigerators and must be stored in refrigerated chambers … The Ministry of Health and ANVISA provided a two-year deadline for implementation” [SITS2 – Northeast]. However, implementation remained incomplete in some settings: “We know that we will still find one or another [facility] with a domestic refrigerator, but we always advise them to switch to a refrigerated chamber…” [RITS1 – South]. Participants’ reports also highlighted the absence of preventive maintenance: “I have been working in this unit since 2017, and I have never had any problems with this domestic refrigerator, but it has never undergone maintenance either … only if it breaks down” [NUR3 – Northeast]. “The central storage facility [municipal level] is a domestic refrigerator located somewhere that has no generator and lacks the infrastructure of a cold-chain center” [RITS5 – Northeast]. Bureaucratic processes and delays in the procurement of equipment, materials, and supplies within Brazil’s public sector represent significant challenges for cold chain management: “We also have bidding processes [public process for contracting goods and services] which take at least three months. So, after this bid, you still have to wait for the company to sign the work order, which takes another month… there is delivery time from the supplier and sometimes it takes a while” [SITS6 - Northeast]. “We don’t manage the issue of financial resources, so we can’t buy. It really depends on state processes… sometimes we need a certain material, a certain equipment, and it takes a while for it to actually arrive. It’s not all that easy, because there’s a lot of bureaucracy” [RITS7 - Northeast]. “They [companies] say they will guarantee the equipment and, in the end, when it comes to delivery, they do not have the equipment that we described in the bid and it ends up making delivery difficult” [SITS11 - Center-West]. Cold chain management may be more challenging in the absence of a regional support structure. The lack of intermediate regional levels in the state of Rio de Janeiro may introduce additional complexities for the functioning of the cold chain: “Another problem is the fact that we have a single state center, and there is this issue of centralization of distribution; this also harms a lot, because we have 92 municipalities to serve. There are municipalities up to 700 km away, and this causes us some inconvenience. So, this lack of regional offices greatly harms the state, considering that our center is small and is where all the storage of immunobiological agents to serve the state is located” [SITS9 - Southeast]. In a similar context, the state of Amazonas has only one regional unit responsible for distributing immunobiologicals to five municipalities, while the state-level authority is directly responsible for the remaining 56 municipalities: “We have already thought about creating new regions, but there would have to be both the issue logistics as well as human resources. And this human resource would be through the State Department of Health via health surveillance. And I know that people have tried several times and failed” [SITS9 - North]. Outsourcing of cold chain operations may pose management challenges, and insufficient responsiveness from contracted providers may compromise its effectiveness: “The service is divided into an administrative part, which is the state, and the executing part, which is the company service provider… we have the issue of human resources, which is not from the state… the people in the contracted company do not always have the capacity to handle it. Here [state] the team only has three technicians to keep track of everything. There [company] they don’t solve anything. What happens there, they call us here [state], and we are the ones who have to give the answer” [SITS9 - Southeast]. Work processes in vaccination rooms play a crucial role in the conservation of immunobiologicals, ensuring the availability of effective products and, consequently, the maintenance of vaccination coverage. Managers committed to improving vaccination coverage are more likely to identify gaps in vaccine delivery and issues related to cold chain maintenance, which may help explain the observed association between higher vaccination coverage and a greater likelihood of adequate cold chain performance in municipalities: “Now in recent months [2022], we have been working hard on this issue of low coverage… we are providing financial resources to help municipalities with vaccination strategies to increase vaccination coverage” [SITS11 - South]. Integration of quantitative and qualitative data was performed using joint displays, linking the “always” response category of EACI items to qualitative inferences and the corresponding meta-inferences derived from participants’ statements. This approach aimed to elucidate underlying mechanisms and contextual factors influencing the observed results (Fig. 4). Joint display integrating quantitative and qualitative findings and their corresponding meta-inferences, Brazil, 2022. a Results are expressed based on the “always” response category of the Immunobiological Agent Conservation Assessment Scale (n = absolute frequency; % = relative frequency) Discussion The findings of this study highlight weaknesses in the performance of the immunobiological cold chain in vaccination rooms within Primary Health Care units in Brazil, with a predominance of inadequate classification at the national level. Nevertheless, three of the five regions presented favorable results, reinforcing that the country’s regional diversity and inequalities directly influence cold chain performance. Cold chain performance was associated with geographic factors (urban location) and service-related factors (DTPw-HB/Hib vaccination coverage). These findings, interpreted as associations, contribute to understanding the contexts in which vaccination rooms operate in Brazil and may support decision-making aimed at developing preventive interventions and mitigating barriers that affect the quality of the Brazilian National Immunization Program. Furthermore, qualitative findings helped elucidate the underlying mechanisms of these associations, highlighting how structural, logistical, and organizational factors interfere with cold chain performance. International studies report recurrent challenges in cold chain management, including limited storage capacity, use of inadequate equipment, lack of preventive maintenance, failures in temperature monitoring, and weaknesses in supervision [13, 17, 32–38]. In Latin America, evaluations remain incipient compared with those conducted in African and European countries. However, studies in Mexico and Brazil also report difficulties in maintaining the cold chain [18, 19, 39–43], corroborating the findings of this study. The integration of qualitative data provided further insight, indicating that these weaknesses are not only technical but also related to managerial, geographic, and economic factors. The availability of adequate equipment, in good condition and in sufficient quantity, is essential for proper cold chain performance and the safe provision of immunobiologicals [15, 16, 44]. In this study, the continued use of domestic refrigerators in vaccination rooms was observed, consistent with national and international findings [16, 32, 34, 39, 45, 46]. Qualitative data highlighted the importance of adherence to Brazilian National Immunization Program guidelines as a strategy to ensure proper conservation of immunobiologicals; however, financial constraints and weaknesses in municipal management were identified as barriers to effective implementation. Although vaccination rooms are guided by national regulations, their structure and organization are the responsibility of state and municipal governments [8, 20, 39, 42]. Lower performance was observed in the North and Northeast regions, which may be related to geographic and economic inequalities within the country. Disparities in financial transfers between municipalities, influenced by geographic location, population size, and management capacity, may compromise the availability and quality of health services [47, 48]. Previous studies have also reported less favorable conditions in vaccination rooms in these regions, reflecting known inequalities in financial investment and human resources [49–51]. In addition, socioeconomic differences, such as higher poverty levels in some Northeastern states compared to the South, may influence the availability of resources necessary for sustaining the cold chain [52]. These findings are consistent with the present study, which indicates greater financial investment in the South and Southeast regions. An association was observed between higher DTPw-HB/Hib vaccination coverage and better cold chain performance. Although vaccination coverage is an important indicator of Brazilian National Immunization Program performance, this relationship should be interpreted with caution. More structured cold chain systems may contribute to higher vaccination coverage, suggesting the possibility of reverse causality. Furthermore, the cross-sectional design does not allow determination of the direction of this association. Evidence from other settings supports this relationship. In Timor-Leste, failures in the availability and storage of immunobiologicals resulted in missed opportunities for vaccination [53]. In Brazil, higher vaccination coverage has been associated with better structural conditions in vaccination rooms [54, 55]. However, vaccination coverage is also influenced by broader socioeconomic factors [50–52, 56, 57]. Urban location was also associated with better cold chain performance. Vaccination rooms in urban areas tend to have greater accessibility, better storage infrastructure, and increased supervision [57]. In contrast, rural areas often face geographic barriers, infrastructure limitations, and challenges related to electricity supply, which may compromise the proper storage and transportation of immunobiologicals. The transportation of immunobiologicals represents a critical component of the cold chain and is often affected by lack of continuous monitoring and inadequacy of transport conditions [9, 17, 58]. These findings are consistent with the present study. Geographic barriers, particularly in rural areas, may further exacerbate logistical challenges and increase the risk of temperature excursions and losses of immunobiologicals [9, 57]. Losses of immunobiologicals due to failures in the cold chain remain a persistent problem and may worsen with the ongoing expansion of immunization programs and the incorporation of new vaccines [5, 59, 60]. This scenario becomes more critical during large-scale vaccination campaigns, such as the COVID-19 pandemic, which required a substantial expansion of cold chain capacity and highlighted challenges related to infrastructure, monitoring, human resources, and funding [10, 11, 21, 58]. These challenges are particularly pronounced in developing countries such as Brazil. In addition, climate change may exacerbate these challenges by increasing extreme events, temperature variability, and instability in electricity supply, all of which may compromise cold chain integrity [10, 61]. In the Brazilian context, particularly in regions with higher temperatures and structural vulnerabilities, these effects may be even more pronounced, directly impacting the conservation of immunobiologicals. Therefore, continuous and comprehensive assessments of the cold chain are essential to identify vulnerabilities, guide interventions, and ensure the sustainability, effectiveness, and safety of immunobiological supply. Regarding limitations, the self-reported nature of the EACI may have led to underestimation or overestimation of certain aspects of vaccination room performance. Additionally, data collection via online platforms may have limited interaction between researchers and participants. The absence of sampling weights and the cross-sectional design also restrict the generalizability of findings and the ability to infer causality. Nevertheless, considering the national scope of the study and the constraints imposed by the COVID-19 pandemic, the adopted strategies enabled the collection of relevant data and contribute to advancing knowledge on the performance and diversity of the cold chain in Brazil. Conclusions The performance of the immunobiological cold chain in Brazil was classified as inadequate, particularly in municipalities in the North and Northeast regions. Factors associated with this performance and, consequently, with the sustainability of the National Immunization Program include geographic characteristics, such as large territorial extension and climatic diversity, which mainly affect the transportation of immunobiologicals, as well as limitations in physical infrastructure, regional financial inequalities, and weaknesses in municipal-level management. The findings highlight the need for investments to strengthen cold chain infrastructure, particularly through the replacement of domestic refrigerators with refrigerated chambers, the acquisition of climate control equipment, alternative power sources, and appropriate temperature monitoring devices, especially at local and municipal levels. In addition, the availability of suitable transportation for immunobiologicals should be prioritized. These results also underscore the importance of adopting tailored strategies that consider not only technical aspects but also the geographic and economic specificities of the Brazilian context in cold chain management. Finally, continued research on this topic is essential, as systematic evaluation of the cold chain can help ensure its capacity to maintain adequate conservation of immunobiologicals distributed to the population, as well as to identify innovative practices that can be scaled up to other settings, thereby strengthening the National Immunization Program at the national level. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Abbreviations National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária) Certificate of Presentation for Ethical Consideration (Certificado de Apresentação para Apreciação Ética) Confidence interval Consolidated Standards of Reporting Trials Corona Virus Disease 2019 Pentavalent vaccine (against diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenzae type b) Immunobiological Agent Conservation Assessment Scale (Escala de Avaliação da Conservação de Imunobiológicos) Municipal immunization technical staff Nurse Odds ratio Qualitative Quantitative Regional immunization technical staff State immunization technical staff Nursing technician Author contributions GGA, ICP and VCO contributed to the study conception and design. Material preparation and data collection were performed by GGA and TIXA. Data analysis was conducted by GGA, BSS, EAAG and VCO. The first draft of the manuscript was written by GGA and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Funding This research was supported by Minas Gerais State Research Support Foundation (Fundação de Amparo à Pesquisa do Estado de Minas Gerais) [APQ-00650-21], and Coordination for the Improvement of Higher Education Personnel (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) [001]. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate This study was conducted in accordance with the principles of the Declaration of Helsinki and in compliance with Brazilian National Health Council Resolution No. 466/2012, which regulates research involving human subjects, and was approved by: the Research Ethics Committees of the Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo (Opinion 4,610,079 and CAAE (Certificado de Apresentação para Apreciação Ética - Certificate of Presentation for Ethical Consideration) 43322621,2,0000,5393 / Opinion 8,428,540 and CAAE 43322621,2,0000,5393); the Universidade Federal de São João del-Rei, Center-West Dona Lindu Campus (Opinion 4,747,228 and CAAE 43322621,2,3001,5545); and the Brazilian National Research Ethics Commission (Opinion 4,812,197 and CAAE 43322621,2,3002,0008). Informed consent for participation was obtained from all the participants. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.